Recent Trump administration decisions on drug policy range between punitive and progressive, a display of troubling ...

Katherine Harris with the Baker Institute at Rice University tracks the hemp industry in Texas. She says a more nuanced ...

The Trump administration, in a stark departure from the "Just Say No" era, is funding psychedelics research and rescheduling ...

San Francisco is moving to upend decades of widely accepted, research-based policy on housing and substance use—and other ...

There is bipartisan consensus that drugs in the U.S. cost a lot more than in other high-income countries; therefore, it is important to comprehend how governmental interventions in other nations can ...

Novartis' CEO warned Tuesday that U.S. drug pricing policy under President Donald Trump poses a "very difficult situation." ...

Progressive “harm reduction” advocates have insisted for decades that active users should take a central role in crafting drug policy. While this belief is profoundly reckless—akin to letting drunk ...

Cities with supervised drug use sites saw the same amount of overdoses. Charles Fain Lehman is a senior fellow at the ...

ELKHART, Ind. (WSBT) — An author on marijuana myths and former drug policy advisor to the Obama administration is making his way to Elkhart Tuesday night. Kevin Sabet is joining a local drug-free ...

Most Favored Nation (MFN) drug pricing is just price controls by another name. Instead of openly capping what a drug can cost ...